Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Encompass Health (EHC)

NYSE Health Care Health Care Facilities S&P MidCap 400
$137.54
-3.73 (-2.64%)
Close of Nov 06, 2026 · end-of-day data
Source: Encompass Health's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$3.64B$3.91B$4.28B$4.61B$3.57B$4.01B$4.35B$4.80B$5.37B$5.94B
Operating income$588.10M$578.30M$555.20M$612.10M$563.90M$559.60M$539.50M———
Interest expense$172.10M$154.40M$147.30M$159.70M$183.70M$164.30M$175.70M$143.50M$137.40M$123.20M
Pre-tax income$482.00M$496.40M$493.20M$562.30M$352.90M$505.00M$450.80M$607.20M$749.60M$953.00M
Income tax$163.90M$145.80M$118.90M$115.90M$74.70M$101.90M$100.10M$132.20M$150.20M$192.90M
Net income$247.60M$271.10M$292.30M$358.70M$284.20M$412.20M$271.00M$352.00M$455.70M$566.20M
EBITDA$760.70M$762.10M$754.90M$830.80M$766.90M$779.20M$783.10M———
EPS (basic)$2.77$2.88$2.98$3.65$2.87$4.15$2.72$3.51$4.53$5.62
EPS (diluted)$2.59$2.84$2.93$3.61$2.85$4.11$2.70$3.47$4.46$5.54
Diluted shares99.50M99.30M99.80M99.40M99.80M100.20M100.40M101.30M102.20M102.20M
Operating margin16.1%14.8%13.0%13.3%15.8%13.9%12.4%———
Net margin6.8%6.9%6.8%7.8%8.0%10.3%6.2%7.3%8.5%9.5%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$40.50M$54.40M$69.20M$60.00M$185.60M$49.40M$21.80M$69.10M$85.40M$72.20M
Receivables$432.00M$459.50M$459.90M$498.70M$563.00M$502.10M$524.80M$599.80M$593.00M$613.40M
Total current assets$654.50M$702.20M$662.10M$755.80M$948.60M$921.40M$717.20M$841.80M$886.90M$905.90M
Goodwill$1.93B$1.97B$2.10B$1.22B$1.23B$1.24B$1.26B$1.28B$1.28B$1.32B
Total assets$4.68B$4.86B$5.17B$6.08B$6.45B$6.86B$5.64B$6.10B$6.53B$7.09B
Total current liabilities$475.60M$517.50M$672.50M$721.00M$717.30M$748.80M$575.90M$656.40M$841.00M$836.40M
Short-term debt$37.10M$32.30M$35.80M$39.30M$38.30M$37.80M$25.20M$24.80M$138.60M$43.60M
Long-term debt$2.98B$2.55B$2.48B$3.02B$3.25B$3.24B$2.74B$2.69B$2.36B$2.45B
Total debt$3.02B$2.58B$2.51B$3.06B$3.29B$3.28B$2.77B$2.71B$2.50B$2.49B
Total liabilities$3.61B$3.25B$3.36B$4.15B$4.44B$4.47B$3.77B$3.81B$3.69B$3.81B
Shareholders' equity$735.90M$1.15B$1.28B$1.35B$1.59B$1.91B$1.31B$1.65B$2.07B$2.44B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$640.20M$658.30M$762.40M$635.30M$704.70M$715.80M$705.80M$850.80M$1.00B$1.18B
Capital expenditures$177.70M$225.80M$254.50M$372.40M$392.80M$524.60M$564.80M$583.10M$642.50M$736.40M
Free cash flow$462.50M$432.50M$507.90M$262.90M$311.90M$191.20M$141.00M$267.70M$360.30M$439.20M
Investing cash flow-$229.90M-$283.00M-$424.50M-$657.40M-$407.50M-$666.30M-$627.00M-$602.80M-$653.30M-$764.60M
Financing cash flow-$416.40M-$359.90M-$321.20M$48.20M-$145.90M-$240.10M-$145.70M-$197.20M-$330.60M-$431.20M
Dividends paid$83.80M$91.50M$100.80M$108.70M$111.80M$112.20M$99.00M$60.40M$62.80M$71.10M
Share buybacks$65.60M$38.10M$0$45.90M$6.10M$0$0$0$31.10M$158.00M
Stock-based compensation$27.40M$47.70M$85.90M$114.40M$25.60M$29.10M$29.20M$50.60M$48.30M$56.50M
Depreciation & amortization$172.60M$183.80M$199.70M$218.70M$203.00M$219.60M$243.60M$273.90M$299.60M$327.90M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.